Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference28 articles.
1. Cyclin dependent kinase (CDK) inhibitors as anticancer drugs;Sanchez-Martinez;Bioorg Med Chem Lett,2015
2. Cyclin-dependent kinases;Malumbres;Genome Biol,2014
3. Inhibitors of cyclin-dependent kinases as cancer therapeutics;Whittaker;Pharmacol Ther,2017
4. Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials;Panagiotou;Clin Transl Oncol,2022
5. Cyclin-dependent kinase 4/6 (cdk4/6) inhibitors: perspectives in cancer therapy and imaging;Graf;Mini Rev Med Chem,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11
2. Pyrazine-based small molecule kinase inhibitors: clinical applications and patent review (2019–2023);Future Medicinal Chemistry;2024-08-27
3. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets;Molecular Cancer;2024-06-07
4. Discovery of novel co-degradation CK1α and CDK7/9 PROTACs with p53 activation for treating acute myeloid leukemia;Bioorganic Chemistry;2024-06
5. Targeting Super-Enhancer–Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance;Cancer Research;2024-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3